VETERINARY SURGEONS SUPPLY COMPANY LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +6.8%

  £86,352,802 → £92,226,559

• Cash

  +42.7%

  £5,431,803 → £7,752,957

• Net assets

  +7.7%

  £9,923,889 → £10,688,783

• Employees

  +1.8%

  55 → 56

• Operating profit

  +3.8%

  £1,266,759 → £1,314,581

• Profit before tax

  +7.1%

  £1,510,462 → £1,618,027

• Wages

  +0.7%

  £2,115,356 → £2,130,818

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

GMCG LISBURN

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Group structure

1. VETERINARY SURGEONS SUPPLY COMPANY LIMITED · parent
   1. VSSCO Veterinary Practice Ltd 100% · United Kingdom · Dormant

Significant events

• “The company continues to invest significantly in I.T., which is necessary to future-proof the business.”
• “The results above incorporate retrospective rebates which this year have been approved by the Board at £1,472,373 (2024 - £1,371,385).”
• “In order to prepare for the end of the grace period with respect to Veterinary Medicines, we have leased additional warehousing nearby our current warehouse. This allow us to increase slock holding as required to minimize the impact of disruptions in supply around the end of the grace period. We have also made a significant investment in a new fridge to give us additional refrigerated pallet storage space.”
• “Corporate acquisitions have slowed down in the Northern Irish market. All NI corporate practices continue to purchase through VSSCo.”
• “We continue to trade with a number of Agricultural merchants in Northern Ireland and hope to expand this going forwards and also supply into some pet retail stores in 2026.”
• “Our ROI turnover grew 9% in 2025 to £1,819,918 (2024 £1,669,403), the aim in the next financial year is to see continued growth in this sector of our business as we have increased the focus with additional sales resource and targeted telesales campaigns.”
• “The dependence of the Northern Ireland economy on the Agri-food sector coupled with the expectation that demand for animal protein will continue to increase over the next decade, should be positive in the long term.”
• “Currently there are ongoing IT projects as we broaden our ecommerce offering both from a pet owner perspective and a business to customer perspective particularly for Agricultural Merchants.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.